ANUHPHR: Sequential revenue and profit decline offset by year-over-year growth and leadership addition
· Issued by Anuh Pharma Limited
Revenue and net profit declined sequentially but showed year-over-year growth, with EBITDA margins narrowing. Appointment of a new Chief Marketing Officer aims to strengthen global business development.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
